Stocktoria
Cue Biopharma, Inc. CUE
Cue Biopharma, Inc. statistics & valuation
Market cap$106.6M
P / S3.9×
P / B4.0×
Net margin-96.9%
Return on equity-100.6%
FCF margin-79.6%
Return on capital-92.5%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -96.7% | -446.9% | -949.9% | -4275.1% | -292.6% | -1428.0% | -1063.2% | -3386.7% | — |
| Net margin | -96.9% | -438.0% | -924.1% | -4257.8% | -295.6% | -1419.8% | -1061.2% | -3411.5% | — |
| FCF margin | -79.6% | -391.9% | -727.9% | -3371.6% | -266.0% | -1049.0% | -891.9% | -2473.8% | — |
| Return on assets | -63.0% | -126.4% | -82.5% | -58.1% | -53.0% | -45.0% | -51.3% | -85.9% | -34.7% |
| Return on equity | -100.6% | -232.4% | -136.8% | -80.7% | -67.4% | -56.8% | -67.2% | -114.7% | -37.7% |
| Debt / equity | — | 0.00× | 0.11× | 0.12× | 0.00× | — | — | — | — |
| Current ratio | 2.74 | 1.84 | 3.01 | 6.68 | 5.35 | 5.36 | 5.24 | 6.53 | 12.17 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.